Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Alongi

Showing results (221-230 of 305) with videos related to

Pageof 31
Sort By:
Anticancer Research|October 15, 2013
Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancerFilippo Alongi, Luca Cozzi, Antonella Fogliata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
Radiation Oncology (London, England)|July 10, 2013
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II studyFilippo Alongi, Luca Cozzi, Stefano Arcangeli, et al.
Tumori|February 8, 2014
Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meetingBerardino De Bari, Alba Fiorentino, Daniela Greto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2013
Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC)Pierina Navarria, Anna Maria Ascolese, Pietro Mancosu, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 22, 2020
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session timeRuggero Ruggieri, Michele Rigo, Stefania Naccarato, et al.
Archives of Dermatological Research|July 17, 2021
Cutaneous soft tissue sarcomas: survival-related factorsAreti Gkantaifi, Alexandros Diamantis, Davide Mauri, et al.
The British Journal of Radiology|July 20, 2021
Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancerRosario Mazzola, Gianluisa Sicignano, Francesco Cuccia, et al.
Physics and Imaging in Radiation Oncology|November 30, 2023
Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear AcceleratorAronne M Schottstaedt, Eric S Paulson, Jason C Rubenstein, et al.
Pageof 31

Showing results (221-230 of 305) with videos related to

Sort By:
Pageof 31
Anticancer Research|October 15, 2013
Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancerFilippo Alongi, Luca Cozzi, Antonella Fogliata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
Radiation Oncology (London, England)|July 10, 2013
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II studyFilippo Alongi, Luca Cozzi, Stefano Arcangeli, et al.
Tumori|February 8, 2014
Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meetingBerardino De Bari, Alba Fiorentino, Daniela Greto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2013
Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC)Pierina Navarria, Anna Maria Ascolese, Pietro Mancosu, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 22, 2020
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session timeRuggero Ruggieri, Michele Rigo, Stefania Naccarato, et al.
Archives of Dermatological Research|July 17, 2021
Cutaneous soft tissue sarcomas: survival-related factorsAreti Gkantaifi, Alexandros Diamantis, Davide Mauri, et al.
The British Journal of Radiology|July 20, 2021
Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancerRosario Mazzola, Gianluisa Sicignano, Francesco Cuccia, et al.
Physics and Imaging in Radiation Oncology|November 30, 2023
Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear AcceleratorAronne M Schottstaedt, Eric S Paulson, Jason C Rubenstein, et al.
Pageof 31